Affluent Medical S.A.
AFME.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €4 | €1 | €1 | €1 |
| % Growth | 236.4% | -8.6% | -7.7% | – |
| Cost of Goods Sold | €13 | €2 | €2 | €3 |
| Gross Profit | -€9 | -€1 | -€1 | -€1 |
| % Margin | -225.2% | -98% | -82.4% | -88.9% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €14 | €12 | €5 | €5 |
| SG&A Expenses | €14 | €12 | €5 | €5 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€7 | €0 | €8 | €6 |
| Operating Expenses | €6 | €12 | €13 | €11 |
| Operating Income | -€16 | -€13 | -€12 | -€13 |
| % Margin | -381% | -1,067.5% | -887.5% | -912% |
| Other Income/Exp. Net | -€0 | -€4 | -€4 | -€2 |
| Pre-Tax Income | -€16 | -€17 | -€15 | -€15 |
| Tax Expense | -€1 | -€1 | -€0 | -€0 |
| Net Income | -€15 | -€16 | -€15 | -€15 |
| % Margin | -357.9% | -1,278.8% | -1,137.2% | -1,021.4% |
| EPS | -0.37 | -0.54 | -0.81 | -0.8 |
| % Growth | 31.5% | 33.3% | -1.3% | – |
| EPS Diluted | -0.37 | -0.54 | -0.81 | -0.8 |
| Weighted Avg Shares Out | 39 | 29 | 19 | 19 |
| Weighted Avg Shares Out Dil | 39 | 29 | 19 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €1 | €3 |
| Interest Expense | €0 | €0 | €1 | €3 |
| Depreciation & Amortization | €2 | €2 | €2 | €2 |
| EBITDA | -€13 | -€13 | -€13 | -€11 |
| % Margin | -326.4% | -1,090.1% | -986.9% | -750.4% |